Vanda Pharmaceuticals Inc. (VNDA)
Market Closed
3 Jun, 20:00
$
6. 0900
-0.04
-0.65%
$
382.76M Market Cap
18.48 P/E Ratio
- Div Yield
813,013 Volume
-0.01 Eps
$ 6.13
Previous Close 
Want to track VNDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vanda Pharmaceuticals Inc. (VNDA) Statistics
Valuation metrics
Market Cap 382.76M
Enterprise value 183M
Trailing P/E (ttm) 126
Forward P/E 30.95
PEG ratio 1.97
Price/Sales (ttm) 1.71
Price/Book (mrq) 1.12
Enterprise Value/Revenue 0.84
Enterprise Value/EBITDA -1.2
Overview
Shares outstanding 60.14M
Float 53.82M
Shares short 6.2M
% Held by insiders 0.06%
% Held by institutions 0.79%
Average volume (10 days) 1.07M
Average volume (90 days) 1.15M
Price summary
52-Week low 4.14
52-Week high 9.94
Beta 0.65
50-Day moving average 7.04
200-Day moving average 6.25
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.1%
Operating margin -0.97%
Operational effectiveness
Return on assets -0.19%
Return on equity -0.6%
Income Statement
Revenue (ttm) 217.78M
Revenue per share (ttm) 3.68
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 205.1M
EBITDA -151.98M
Net income to common (ttm) -239.55M
Diluted EPS (ttm) -4.06
Quarterly earnings growth (yoy) 0.03%
Balance Sheet
Total cash (mrq) 202.31M
Total cash per share (mrq) 3.36
Total debt (mrq) 13.07M
Total Debt/Equity (mrq) 4.66
Current ratio (mrq) 2.16%
Book value per share (mrq) 5.54
Cash Flow
Cash flow statement -126.51M
Levered free cash flow (LFCF) -83.15M
